The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (reiwa Study)
JTO CLINICAL AND RESEARCH REPORTS（2024）
关键词
Osimertinib,EGFR,Non-small cell lung cancer,Progression patterns,Post-progression treatments
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要